PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9876334-7 1998 Cardiovascular effects were assessed as isoprenaline (3.5-35 ng/kg/min)- and terbutaline (25-150 ng/kg/min)-infusion-induced increases in heart rate and systolic blood pressure, decreases in diastolic blood pressure and shortening of the systolic time intervals (STIs), heart rate corrected duration of electromechanical systole (QS2c) and pre-ejection period (PEP; as a measure of inotropism). Terbutaline 77-88 progestagen associated endometrial protein Homo sapiens 361-364 9876334-9 1998 Isoprenaline- and terbutaline-infusion caused dose-dependent increases in systolic blood pressure and heart rate, decreases in diastolic blood pressure and shortening of QS2c and PEP, whereby isoprenaline effects were more pronounced. Terbutaline 18-29 progestagen associated endometrial protein Homo sapiens 170-182 9876334-10 1998 After two weeks of treatment with terbutaline p.o., isoprenaline- and terbutaline-infusion-induced increases in heart rate, shortening of QS2c and PEP were significantly reduced whereby terbutaline-infusion effects were markedly more attenuated than isoprenaline-infusion effects. Terbutaline 34-45 progestagen associated endometrial protein Homo sapiens 147-150 9876334-10 1998 After two weeks of treatment with terbutaline p.o., isoprenaline- and terbutaline-infusion-induced increases in heart rate, shortening of QS2c and PEP were significantly reduced whereby terbutaline-infusion effects were markedly more attenuated than isoprenaline-infusion effects. Terbutaline 70-81 progestagen associated endometrial protein Homo sapiens 147-150 9876334-10 1998 After two weeks of treatment with terbutaline p.o., isoprenaline- and terbutaline-infusion-induced increases in heart rate, shortening of QS2c and PEP were significantly reduced whereby terbutaline-infusion effects were markedly more attenuated than isoprenaline-infusion effects. Terbutaline 70-81 progestagen associated endometrial protein Homo sapiens 147-150 1758201-3 1991 PEFR increased significantly after inhaled terbutaline both with and without PEP. Terbutaline 43-54 progestagen associated endometrial protein Homo sapiens 77-80 1758201-4 1991 The mean increase in PEFR after terbutaline inhalations was significantly greater (p less than 0.0001) in the +PEP group (24 L/min) compared to the -PEP group (17 L/min). Terbutaline 32-43 progestagen associated endometrial protein Homo sapiens 111-114